A citation-based method for searching scientific literature

Yangli Xie, Nan Su, Jing Yang, Qiaoyan Tan, Shuo Huang, Min Jin, Zhenhong Ni, Bin Zhang, Dali Zhang, Fengtao Luo, Hangang Chen, Xianding Sun, Jian Q Feng, Huabing Qi, Lin Chen. Signal Transduct Target Ther 2020
Times Cited: 52







List of co-cited articles
279 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Fibroblast Growth Factor signaling pathway.
David M Ornitz, Nobuyuki Itoh. Wiley Interdiscip Rev Dev Biol 2015
896
34

Fibroblast growth factor signalling: from development to cancer.
Nicholas Turner, Richard Grose. Nat Rev Cancer 2010
19

Cell signaling by receptor tyrosine kinases.
Mark A Lemmon, Joseph Schlessinger. Cell 2010
17

The FGF family: biology, pathophysiology and therapy.
Andrew Beenken, Moosa Mohammadi. Nat Rev Drug Discov 2009
15

Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach.
Marco Presta, Paola Chiodelli, Arianna Giacomini, Marco Rusnati, Roberto Ronca. Pharmacol Ther 2017
90
11

The Klotho proteins in health and disease.
Makoto Kuro-O. Nat Rev Nephrol 2019
167
11


VEGF in Signaling and Disease: Beyond Discovery and Development.
Rajendra S Apte, Daniel S Chen, Napoleone Ferrara. Cell 2019
428
9

Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors.
Shuyan Dai, Zhan Zhou, Zhuchu Chen, Guangyu Xu, Yongheng Chen. Cells 2019
76
9

Cellular signaling by fibroblast growth factor receptors.
V P Eswarakumar, I Lax, J Schlessinger. Cytokine Growth Factor Rev 2005
9

Targeting Cellular Trafficking of Fibroblast Growth Factor Receptors as a Strategy for Selective Cancer Treatment.
Natalia Porębska, Marta Latko, Marika Kucińska, Małgorzata Zakrzewska, Jacek Otlewski, Łukasz Opaliński. J Clin Med 2018
32
15

Advances and challenges in targeting FGFR signalling in cancer.
Irina S Babina, Nicholas C Turner. Nat Rev Cancer 2017
298
9


The ins and outs of fibroblast growth factor receptor signalling.
Stacey J Coleman, Charo Bruce, Athina-Myrto Chioni, Hemant M Kocher, Richard P Grose. Clin Sci (Lond) 2014
34
14

Fibroblast growth factors and their receptors in cancer.
Jørgen Wesche, Kaisa Haglund, Ellen Margrethe Haugsten. Biochem J 2011
351
9

Exploring mechanisms of FGF signalling through the lens of structural biology.
Regina Goetz, Moosa Mohammadi. Nat Rev Mol Cell Biol 2013
322
9

Structural basis for FGF receptor dimerization and activation.
A N Plotnikov, J Schlessinger, S R Hubbard, M Mohammadi. Cell 1999
448
7

Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.
J Schlessinger, A N Plotnikov, O A Ibrahimi, A V Eliseenkova, B K Yeh, A Yayon, R J Linhardt, M Mohammadi. Mol Cell 2000
830
7




TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.
Lipika Goyal, Lei Shi, Leah Y Liu, Ferran Fece de la Cruz, Jochen K Lennerz, Srivatsan Raghavan, Ignaty Leschiner, Liudmila Elagina, Giulia Siravegna, Raymond W S Ng,[...]. Cancer Discov 2019
113
7

Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.
Chiara Degirolamo, Carlo Sabbà, Antonio Moschetta. Nat Rev Drug Discov 2016
215
7

Targeting FGFR Signaling in Cancer.
Mehdi Touat, Ecaterina Ileana, Sophie Postel-Vinay, Fabrice André, Jean-Charles Soria. Clin Cancer Res 2015
263
7

Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma.
Lipika Goyal, Supriya K Saha, Leah Y Liu, Giulia Siravegna, Ignaty Leshchiner, Leanne G Ahronian, Jochen K Lennerz, Phuong Vu, Vikram Deshpande, Avinash Kambadakone,[...]. Cancer Discov 2017
211
7

Fibroblast growth factor (FGF) signaling in development and skeletal diseases.
Chad M Teven, Evan M Farina, Jane Rivas, Russell R Reid. Genes Dis 2014
104
7

Fibroblast growth factors.
D M Ornitz, N Itoh. Genome Biol 2001
7

The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors.
Irit Lax, Andy Wong, Betty Lamothe, Arnold Lee, Adam Frost, Jessica Hawes, Joseph Schlessinger. Mol Cell 2002
116
7

Antibody-induced dimerization of FGFR1 promotes receptor endocytosis independently of its kinase activity.
Łukasz Opaliński, Aleksandra Sokołowska-Wędzina, Martyna Szczepara, Małgorzata Zakrzewska, Jacek Otlewski. Sci Rep 2017
16
25

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.
Nicholas Turner, Alex Pearson, Rachel Sharpe, Maryou Lambros, Felipe Geyer, Maria A Lopez-Garcia, Rachael Natrajan, Caterina Marchio, Elizabeth Iorns, Alan Mackay,[...]. Cancer Res 2010
468
7

FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalization.
Marta Pozniak, Aleksandra Sokolowska-Wedzina, Kamil Jastrzebski, Jakub Szymczyk, Natalia Porebska, Mateusz Adam Krzyscik, Malgorzata Zakrzewska, Marta Miaczynska, Jacek Otlewski, Lukasz Opalinski. Mol Oncol 2020
6
66

The alternatively spliced acid box region plays a key role in FGF receptor autoinhibition.
Juliya Kalinina, Kaushik Dutta, Dariush Ilghari, Andrew Beenken, Regina Goetz, Anna V Eliseenkova, David Cowburn, Moosa Mohammadi. Structure 2012
48
6

Molecular mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signaling.
Corentin Herbert, Ulrich Schieborr, Krishna Saxena, Jarek Juraszek, Frederik De Smet, Chantal Alcouffe, Marc Bianciotto, Giorgio Saladino, David Sibrac, Denis Kudlinzki,[...]. Cancer Cell 2013
74
5

PDGF in organ fibrosis.
Barbara Mara Klinkhammer, Jürgen Floege, Peter Boor. Mol Aspects Med 2018
69
5

Molecular mediators of angiogenesis.
Areck A Ucuzian, Andrew A Gassman, Andrea T East, Howard P Greisler. J Burn Care Res 2010
194
5

Fibroblast growth factors: biology, function, and application for tissue regeneration.
Ye-Rang Yun, Jong Eun Won, Eunyi Jeon, Sujin Lee, Wonmo Kang, Hyejin Jo, Jun-Hyeog Jang, Ueon Sang Shin, Hae-Won Kim. J Tissue Eng 2010
278
5

FGF signalling during embryo development regulates cilia length in diverse epithelia.
Judith M Neugebauer, Jeffrey D Amack, Annita G Peterson, Brent W Bisgrove, H Joseph Yost. Nature 2009
182
5

Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
Guang Liang, Lintao Song, Zilu Chen, Yuanyuan Qian, Junjun Xie, Longwei Zhao, Qian Lin, Guanghui Zhu, Yi Tan, Xiaokun Li,[...]. Kidney Int 2018
63
5

FGF/FGFR signaling pathway involved resistance in various cancer types.
Yangyang Zhou, Chengyu Wu, Guangrong Lu, Zijing Hu, Qiuxiang Chen, Xiaojing Du. J Cancer 2020
21
14

Identification of targetable FGFR gene fusions in diverse cancers.
Yi-Mi Wu, Fengyun Su, Shanker Kalyana-Sundaram, Nickolay Khazanov, Bushra Ateeq, Xuhong Cao, Robert J Lonigro, Pankaj Vats, Rui Wang, Su-Fang Lin,[...]. Cancer Discov 2013
441
5

Future applications of FGF/FGFR inhibitors in cancer.
Gaia Cristina Ghedini, Roberto Ronca, Marco Presta, Arianna Giacomini. Expert Rev Anticancer Ther 2018
36
8

The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing.
Teresa Helsten, Sheryl Elkin, Elisa Arthur, Brett N Tomson, Jennifer Carter, Razelle Kurzrock. Clin Cancer Res 2016
284
5

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.
Milind Javle, Maeve Lowery, Rachna T Shroff, Karl Heinz Weiss, Christoph Springfeld, Mitesh J Borad, Ramesh K Ramanathan, Lipika Goyal, Saeed Sadeghi, Teresa Macarulla,[...]. J Clin Oncol 2018
264
5

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
5

FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib.
Lixia Gao, Xuli Wang, Yaoliang Tang, Shuang Huang, Chien-An Andy Hu, Yong Teng. J Exp Clin Cancer Res 2017
81
5

Cancer Mutations in FGFR2 Prevent a Negative Feedback Loop Mediated by the ERK1/2 Pathway.
Patrycja Szybowska, Michal Kostas, Jørgen Wesche, Antoni Wiedlocha, Ellen Margrethe Haugsten. Cells 2019
7
42

Targeting the fibroblast growth factor receptor family in cancer.
Niamh Hallinan, Stephen Finn, Sinead Cuffe, Shereen Rafee, Kenneth O'Byrne, Kathy Gately. Cancer Treat Rev 2016
72
5

Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance.
Melanie A Krook, Julie W Reeser, Gabrielle Ernst, Hannah Barker, Max Wilberding, Gary Li, Hui-Zi Chen, Sameek Roychowdhury. Br J Cancer 2021
16
18

FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor.
Koichi Azuma, Akihiko Kawahara, Kahori Sonoda, Kazutaka Nakashima, Kousuke Tashiro, Kosuke Watari, Hiroto Izumi, Masayoshi Kage, Michihiko Kuwano, Mayumi Ono,[...]. Oncotarget 2014
78
5

Identification of a new fibroblast growth factor receptor, FGFR5.
M Sleeman, J Fraser, M McDonald, S Yuan, D White, P Grandison, K Kumble, J D Watson, J G Murison. Gene 2001
185
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.